Literature DB >> 11748142

rolling pebbles (rols) is required in Drosophila muscle precursors for recruitment of myoblasts for fusion.

A Rau1, D Buttgereit, A Holz, R Fetter, S K Doberstein, A Paululat, N Staudt, J Skeath, A M Michelson, R Renkawitz-Pohl.   

Abstract

Mutations in the rolling pebbles (rols) gene result in severe defects in myoblast fusion. Muscle precursor cells are correctly determined, but myogenesis does not progress significantly beyond this point because recognition and/or cell adhesion between muscle precursor cells and fusion-competent myoblasts is disturbed. Molecular analysis of the rols genomic region reveals two variant transcripts of rols due to different transcription initiation sites, rols6 and rols7. rols6 mRNA is detectable mainly in the endoderm during differentiation as well as in malpighian tubules and in the epidermis. By contrast, rols7 expression is restricted to the mesoderm and later to progenitor descendants during somatic and pharyngeal muscle development. Transcription starts at the extended germ band stage when progenitor/founder cells are determined and persists until stage 13. The proteins encoded by the rols gene are 1670 (Rols6) and 1900 (Rols7) amino acids in length. Both forms contain an N-terminal RING-finger motif, nine ankyrin repeats and a TPR repeat eventually overlaid by a coiled-coil domain. The longer protein, Rols7, is characterized by 309 unique N-terminal amino acids, while Rols6 is distinguishable by 79 N-terminal amino acids. Expression of rols7 in muscle founder cells indicates a function of Rols7 in these cells. Transplantation assays of rols mutant mesodermal cells into wild-type embryos show that Rols is required in muscle precursor cells and is essential to recruit fusion-competent myoblasts for myotube formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748142     DOI: 10.1242/dev.128.24.5061

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  42 in total

Review 1.  Myoblast fusion: lessons from flies and mice.

Authors:  Susan M Abmayr; Grace K Pavlath
Journal:  Development       Date:  2012-02       Impact factor: 6.868

2.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro.

Authors:  Gentian Lluri; Garret D Langlois; Paul D Soloway; Diane M Jaworski
Journal:  Exp Cell Res       Date:  2007-06-27       Impact factor: 3.905

3.  A molecular-properties-based approach to understanding PDZ domain proteins and PDZ ligands.

Authors:  Cosmas Giallourakis; Zhifang Cao; Todd Green; Heather Wachtel; Xiaohui Xie; Marco Lopez-Illasaca; Mark Daly; John Rioux; Ramnik Xavier
Journal:  Genome Res       Date:  2006-07-06       Impact factor: 9.043

4.  The MARVEL domain protein, Singles Bar, is required for progression past the pre-fusion complex stage of myoblast fusion.

Authors:  Beatriz Estrada; Anne D Maeland; Stephen S Gisselbrecht; James W Bloor; Nicholas H Brown; Alan M Michelson
Journal:  Dev Biol       Date:  2007-05-03       Impact factor: 3.582

5.  3D analysis of founder cell and fusion competent myoblast arrangements outlines a new model of myoblast fusion.

Authors:  Karen Beckett; Mary K Baylies
Journal:  Dev Biol       Date:  2007-07-06       Impact factor: 3.582

Review 6.  Visualizing new dimensions in Drosophila myoblast fusion.

Authors:  Brian Richardson; Karen Beckett; Mary Baylies
Journal:  Bioessays       Date:  2008-05       Impact factor: 4.345

7.  Ultrastructural analysis of myoblast fusion in Drosophila.

Authors:  Shiliang Zhang; Elizabeth H Chen
Journal:  Methods Mol Biol       Date:  2008

8.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

9.  Systematic analysis of the transcriptional switch inducing migration of border cells.

Authors:  Lodovica Borghese; Georgina Fletcher; Juliette Mathieu; Ann Atzberger; William C Eades; Ross L Cagan; Pernille Rørth
Journal:  Dev Cell       Date:  2006-04       Impact factor: 12.270

10.  The atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivo.

Authors:  Mélanie Laurin; Nadine Fradet; Anne Blangy; Alan Hall; Kristiina Vuori; Jean-François Côté
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.